BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 27495187)

  • 41. T1 signal intensity in the dentate nucleus after the administration of the macrocyclic gadolinium-based contrast agent gadoterate meglumine: An observational study.
    Ramalho J; Semelka RC; Cruz J; Morais T; Ramalho M
    Radiologia (Engl Ed); 2022; 64(5):397-406. PubMed ID: 36243439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does Gadoterate Meglumine Cause Gadolinium Retention in the Brain of Children? A Case-Control Study.
    Topcuoglu ED; Topcuoglu OM; Semiz Oysu A; Bukte Y
    J Magn Reson Imaging; 2020 May; 51(5):1471-1477. PubMed ID: 31665554
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gadolinium Presence in the Brain After Administration of the Liver-Specific Gadolinium-Based Contrast Agent Gadoxetate: A Systematic Comparison to Multipurpose Agents in Rats.
    Jost G; Frenzel T; Boyken J; Schoeckel L; Pietsch H
    Invest Radiol; 2019 Aug; 54(8):468-474. PubMed ID: 30932931
    [TBL] [Abstract][Full Text] [Related]  

  • 44. T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents.
    Robert P; Lehericy S; Grand S; Violas X; Fretellier N; Idée JM; Ballet S; Corot C
    Invest Radiol; 2015 Aug; 50(8):473-80. PubMed ID: 26107651
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contrast Agent-Induced High Signal Intensity in Dentate Nucleus on Unenhanced T1-Weighted Images: Comparison of Gadodiamide and Gadoxetic Acid.
    Ichikawa S; Motosugi U; Omiya Y; Onishi H
    Invest Radiol; 2017 Jul; 52(7):389-395. PubMed ID: 28195932
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Signal intensity change on unenhanced T1-weighted images in dentate nucleus and globus pallidus after multiple administrations of gadoxetate disodium: an intraindividual comparative study.
    Conte G; Preda L; Cocorocchio E; Raimondi S; Giannitto C; Minotti M; De Piano F; Petralia G; Ferrucci PF; Bellomi M
    Eur Radiol; 2017 Oct; 27(10):4372-4378. PubMed ID: 28357495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Signal changes in enhanced T1-weighted images related to gadolinium retention: A three-time-point imaging study.
    Lersy F; Diepenbroek AL; Lamy J; Willaume T; Bierry G; Cotton F; Kremer S
    J Neuroradiol; 2021 Mar; 48(2):82-87. PubMed ID: 32615207
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Higher magnetic susceptibility of globus pallidus in patients after macrocyclic GBCAs: assessment using quantitative susceptibility mapping.
    Zhang J; Xie L; Yang X; Xu L; Chen K; Luo Y; Yu C
    Acta Radiol; 2023 Jul; 64(7):2261-2267. PubMed ID: 36567675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Age, But Not Repeated Exposure to Gadoterate Meglumine, Is Associated With T1- and T2-Weighted Signal Intensity Changes in the Deep Brain Nuclei of Pediatric Patients.
    Pozeg P; Forget J; Meuli RA; Maeder P
    Invest Radiol; 2019 Sep; 54(9):537-548. PubMed ID: 30973458
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals: A Comparative Study of Macrocyclic Versus Linear Gadolinium Chelates in Renally Sensitized Rats.
    Rasschaert M; Emerit A; Fretellier N; Factor C; Robert P; Idée JM; Corot C
    Invest Radiol; 2018 Jun; 53(6):328-337. PubMed ID: 29329151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Visible T1-hyperintensity of the dentate nucleus after multiple administrations of macrocyclic gadolinium-based contrast agents: yes or no?
    Splendiani A; Corridore A; Torlone S; Martino M; Barile A; Di Cesare E; Masciocchi C
    Insights Imaging; 2019 Sep; 10(1):82. PubMed ID: 31482392
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Signal Intensity Evaluation in the Dentate Nucleus and Subcortical Gray Matter : Effect of Several Administrations of Gadoterate Meglumine in Multiple Sclerosis.
    Hannoun S; Kocevar G; Codjia P; Maucort-Boulch D; Cotton F; Vukusic S; Durand-Dubief F; Sappey-Marinier D
    Clin Neuroradiol; 2022 Sep; 32(3):677-685. PubMed ID: 33630120
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Brain Irradiation and Gadobutrol Administration in Pediatric Patients with Brain Tumors: Effect on MRI Brain Signal Intensity.
    Tamrazi B; Liu CJ; Cen SY; Nelson MB; Dhall G; Nelson MD
    Radiology; 2018 Oct; 289(1):188-194. PubMed ID: 29989524
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High Signal Intensity in Globus Pallidus and Dentate Nucleus on Unenhanced T1-weighted MR Images: Evaluation of Two Linear Gadolinium-based Contrast Agents.
    Ramalho J; Castillo M; AlObaidy M; Nunes RH; Ramalho M; Dale BM; Semelka RC
    Radiology; 2015 Sep; 276(3):836-44. PubMed ID: 26079490
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gadopentetate but not gadobutrol accumulates in the dentate nucleus of multiple sclerosis patients.
    Schlemm L; Chien C; Bellmann-Strobl J; Dörr J; Wuerfel J; Brandt AU; Paul F; Scheel M
    Mult Scler; 2017 Jun; 23(7):963-972. PubMed ID: 27679460
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gadolinium Accumulation in the Deep Cerebellar Nuclei and Globus Pallidus After Exposure to Linear but Not Macrocyclic Gadolinium-Based Contrast Agents in a Retrospective Pig Study With High Similarity to Clinical Conditions.
    Boyken J; Frenzel T; Lohrke J; Jost G; Pietsch H
    Invest Radiol; 2018 May; 53(5):278-285. PubMed ID: 29319556
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative assessment of gadolinium deposition in dentate nucleus using quantitative susceptibility mapping.
    Hinoda T; Fushimi Y; Okada T; Arakawa Y; Liu C; Yamamoto A; Okada T; Yoshida K; Miyamoto S; Togashi K
    J Magn Reson Imaging; 2017 May; 45(5):1352-1358. PubMed ID: 27664936
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol.
    Stojanov DA; Aracki-Trenkic A; Vojinovic S; Benedeto-Stojanov D; Ljubisavljevic S
    Eur Radiol; 2016 Mar; 26(3):807-15. PubMed ID: 26105022
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pediatric Brain: Repeated Exposure to Linear Gadolinium-based Contrast Material Is Associated with Increased Signal Intensity at Unenhanced T1-weighted MR Imaging.
    Flood TF; Stence NV; Maloney JA; Mirsky DM
    Radiology; 2017 Jan; 282(1):222-228. PubMed ID: 27467467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of High Signal Intensity within the Globus Pallidus and Dentate Nucleus following Multiple Administrations of Gadobenate Dimeglumine.
    Bolles GM; Yazdani M; Stalcup ST; Creeden SG; Collins HR; Nietert PJ; Roberts DR
    AJNR Am J Neuroradiol; 2018 Mar; 39(3):415-420. PubMed ID: 29348135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.